Ethical issues in solid organ transplantation: transfusion-free transplantation in Jehovah's witness patients
- PMID: 38054541
- DOI: 10.1097/MOT.0000000000001128
Ethical issues in solid organ transplantation: transfusion-free transplantation in Jehovah's witness patients
Abstract
Purpose of review: Jehovah's Witnesses do not accept transfusion of major allogeneic blood fractions. Successful solid organ transplantation is challenging for Jehovah's Witnesses when anemia, coagulation disturbances, and difficult technical aspects co-exist, and key blood bank resources cannot be utilized. Organ availability for transplantation is limited and demand exceeds supply for all organ types. Historically, the likelihood of poor outcomes in Jehovah's Witnesses patients placed ethical limitations on transplant candidacy for this population violating the precept of maximal utilization of a limited resource. The review's purpose is to describe advancements and strategies that make Jehovah's Witnesses transplant outcomes comparable to transfusion-eligible patients and allay the ethical concerns of their candidacy.
Recent findings: Immunomodulation from allogeneic transfusion is a cause of significant postop morbidity. Blood conservation strategies have led to improved outcomes across different medical and surgical cohorts and set the stage for expanded utility in Jehovah's Witnesses with organ insufficiency.Published single-center series with descriptions of specific peri-operative strategies describe the path to major blood product avoidance.
Summary: Comparable outcomes in solid organ transplantation for Jehovah's Witnesses without allogeneic transfusion are possible when inclusion-exclusion criteria are respected, and blood conservation strategies employed.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- UNOS Policy | OPTN Policy Changes and Organ Allocation Guidelines. https://unos.org/policy/ [Accessed 14 August 2023]
-
- Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693–699.
-
- Zhu J, Chen P, Frankel M, et al. Contemporary policies regarding alcohol and marijuana use among Liver Transplant Programs in the United States. Transplantation 2018; 102:433–439.
-
- Bodnaruk Z, Wong C, Thomas J. Meeting the clinical challenge of care for Jehovah's Witnesses. Transfus Med Rev 2004; 18:105–116.
-
- Bramstedt K. Transfusion contracts for Jehovah's Witnesses receiving organ transplants: ethical necessity or coercive pact? J Med Ethics 2006; 32:193–195.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
